| Nome |
# |
|
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer, file e0d6c92d-05f3-fcf8-e053-d805fe0aa794
|
481
|
|
Cabozantinib in Thyroid Cancer, file e0d6c92c-8aec-fcf8-e053-d805fe0aa794
|
461
|
|
Sorafenib in the treatment of thyroid cancer, file e0d6c926-b2b4-fcf8-e053-d805fe0aa794
|
408
|
|
Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer, file e0d6c92c-6cdb-fcf8-e053-d805fe0aa794
|
346
|
|
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases, file e0d6c92c-94f7-fcf8-e053-d805fe0aa794
|
285
|
|
Acquired Carotid-Jugular Fistula: Its Changing History and Management, file e0d6c926-416d-fcf8-e053-d805fe0aa794
|
277
|
|
Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer, file e0d6c926-b89d-fcf8-e053-d805fe0aa794
|
254
|
|
Aggressive thyroid cancer: targeted therapy with sorafenib, file e0d6c92d-7936-fcf8-e053-d805fe0aa794
|
169
|
|
The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer, file e0d6c92c-8c5d-fcf8-e053-d805fe0aa794
|
145
|
|
Sorafenib and Thyroid Cancer, file e0d6c92d-344c-fcf8-e053-d805fe0aa794
|
143
|
|
New Therapies for Dedifferentiated Papillary Thyroid Cancer., file e0d6c927-2155-fcf8-e053-d805fe0aa794
|
128
|
|
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update, file e0d6c92d-47ed-fcf8-e053-d805fe0aa794
|
123
|
|
Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study, file e0d6c92b-6080-fcf8-e053-d805fe0aa794
|
111
|
|
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo, file e0d6c92a-c610-fcf8-e053-d805fe0aa794
|
110
|
|
null, file e0d6c926-b2bd-fcf8-e053-d805fe0aa794
|
109
|
|
Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes, file e0d6c92d-c6ee-fcf8-e053-d805fe0aa794
|
104
|
|
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features, file e0d6c92b-0abb-fcf8-e053-d805fe0aa794
|
103
|
|
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied, file e0d6c92c-c4c7-fcf8-e053-d805fe0aa794
|
80
|
|
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo, file e0d6c92a-e9af-fcf8-e053-d805fe0aa794
|
76
|
|
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration, file e0d6c92b-c429-fcf8-e053-d805fe0aa794
|
68
|
|
Selective use of vandetanib in the treatment of thyroid cancer, file e0d6c926-b742-fcf8-e053-d805fe0aa794
|
55
|
|
Energy-based devices in thyroid surgery-an overview, file e0d6c92e-c058-fcf8-e053-d805fe0aa794
|
55
|
|
Novel treatment options for anaplastic thyroid cancer, file e0d6c92c-bbab-fcf8-e053-d805fe0aa794
|
41
|
|
Can total thyroidectomy be safely performed by residents? A comparative retrospective multicenter study, file e0d6c92b-3869-fcf8-e053-d805fe0aa794
|
39
|
|
Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study, file e0d6c92c-a58d-fcf8-e053-d805fe0aa794
|
29
|
|
Mediastinal lymph node metastases in thyroid cancer: surgery without limits, file bbce884c-41f1-4115-b731-7ae359236a32
|
20
|
|
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases, file e0d6c92c-f6b9-fcf8-e053-d805fe0aa794
|
13
|
|
Minimally invasive video-assisted thyroidectomy, file e0d6c926-28dc-fcf8-e053-d805fe0aa794
|
11
|
|
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma, file e0d6c932-4860-fcf8-e053-d805fe0aa794
|
11
|
|
Minimally invasive video-assisted thyroidectomy (MIVAT), file e0d6c92e-c05a-fcf8-e053-d805fe0aa794
|
9
|
|
Factors associated with postoperative hypocalcemia following thyroidectomy in childhood, file e0d6c931-b630-fcf8-e053-d805fe0aa794
|
9
|
|
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo, file e0d6c926-4180-fcf8-e053-d805fe0aa794
|
8
|
|
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion, file e0d6c92f-f79a-fcf8-e053-d805fe0aa794
|
8
|
|
A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma, file 32e7daef-1cd9-4185-9f81-2bbc44336946
|
7
|
|
The endoscopic approach to the neck: a
review of the literature and an overview of the various techniques, file e0d6c926-0f0e-fcf8-e053-d805fe0aa794
|
7
|
|
Minimally invasive video-assisted thyroidectomy: five years of experience, file e0d6c926-222c-fcf8-e053-d805fe0aa794
|
7
|
|
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo, file e0d6c926-4715-fcf8-e053-d805fe0aa794
|
7
|
|
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied, file e0d6c92a-e3b8-fcf8-e053-d805fe0aa794
|
7
|
|
Molecular alterations in relation to histopathological characteristics in a large series of pediatric papillary thyroid carcinoma from a single institution, file e0d6c931-863b-fcf8-e053-d805fe0aa794
|
7
|
|
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation, file e0d6c926-3b4e-fcf8-e053-d805fe0aa794
|
6
|
|
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro, file e0d6c926-470f-fcf8-e053-d805fe0aa794
|
6
|
|
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience, file f5ef1653-4c08-425c-b848-7425106cb6ba
|
6
|
|
Minimally Invasive Video-Assisted Parathyroidectomy: Lesson Learned from 137 cases, file e0d6c926-34eb-fcf8-e053-d805fe0aa794
|
5
|
|
CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation, file e0d6c929-6287-fcf8-e053-d805fe0aa794
|
5
|
|
Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer, file e0d6c931-2ac6-fcf8-e053-d805fe0aa794
|
5
|
|
Sorafenib in the treatment of thyroid cancer, file e0d6c927-f349-fcf8-e053-d805fe0aa794
|
4
|
|
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update, file e0d6c92d-4e50-fcf8-e053-d805fe0aa794
|
4
|
|
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction?, file e0d6c926-4489-fcf8-e053-d805fe0aa794
|
3
|
|
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology?, file e0d6c926-652d-fcf8-e053-d805fe0aa794
|
3
|
|
Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures., file e0d6c928-045c-fcf8-e053-d805fe0aa794
|
3
|
|
Aggressive thyroid cancer: targeted therapy with sorafenib, file e0d6c928-2148-fcf8-e053-d805fe0aa794
|
3
|
|
Tyrosine Kinase Inhibitors; Therapies for Thyroid Cancer, file e0d6c928-3c32-fcf8-e053-d805fe0aa794
|
3
|
|
Papillary Thyroid Carcinoma With Rare exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience, file e0d6c930-a815-fcf8-e053-d805fe0aa794
|
3
|
|
Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma, file e0d6c930-ae6f-fcf8-e053-d805fe0aa794
|
3
|
|
Salvage total thyroidectomy for amiodarone-induced thyrotoxicosis in a SARS-CoV-2 positive patient: results of the viral genome research on the pathology sample of this destructive thyroiditis, file e0d6c931-e524-fcf8-e053-d805fe0aa794
|
3
|
|
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas, file 0779ae18-d912-404a-a41d-2748a00c9407
|
2
|
|
No outcome differences between a laparoscopic and retroperitoneoscopic approach in synchronous bilateral adrenal surgery., file e0d6c926-0dd3-fcf8-e053-d805fe0aa794
|
2
|
|
The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer, file e0d6c927-e937-fcf8-e053-d805fe0aa794
|
2
|
|
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study, file e0d6c92c-fdc9-fcf8-e053-d805fe0aa794
|
2
|
|
null, file e0d6c92d-0d88-fcf8-e053-d805fe0aa794
|
2
|
|
null, file e0d6c92d-29cc-fcf8-e053-d805fe0aa794
|
2
|
|
Novel treatments for anaplastic thyroid carcinoma, file e0d6c92e-425f-fcf8-e053-d805fe0aa794
|
2
|
|
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy, file e0d6c92e-74fc-fcf8-e053-d805fe0aa794
|
2
|
|
Day case parathyroidectomy: is this the right way for the patients?, file e0d6c92e-d0d6-fcf8-e053-d805fe0aa794
|
2
|
|
Tailored surgery according to molecular analysis in differentiated thyroid carcinomas, file e0d6c92e-d0dc-fcf8-e053-d805fe0aa794
|
2
|
|
Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer, file e0d6c931-995f-fcf8-e053-d805fe0aa794
|
2
|
|
Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center, file e0d6c931-b047-fcf8-e053-d805fe0aa794
|
2
|
|
Sclerosing Paragangliomas: Correlations of Histological Features with Patients' Genotype and Vesicular Monoamine Transporter Expression, file fd47600e-bee1-48a2-88c9-e2e72fdbf930
|
2
|
|
BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland, file 48d3d5ed-dc7d-42aa-9f37-5aed5b50fb6f
|
1
|
|
Tumor-to-Tumor Metastasis: Lung Typical Carcinoid Metastatic to Follicular Variant of Papillary Thyroid Carcinoma, file 693e1295-c93c-4cd9-b653-69557d3b6508
|
1
|
|
Evaluation of a preoperative pain score in response to pressure as a marker of postoperative pain and drugs consumption in surgical thyroidectomy., file e0d6c926-2e2f-fcf8-e053-d805fe0aa794
|
1
|
|
Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction., file e0d6c926-3f4e-fcf8-e053-d805fe0aa794
|
1
|
|
Mini-invasive video-assisted surgery of the thyroid and parathyroid glands: A 2011 update, file e0d6c926-f597-fcf8-e053-d805fe0aa794
|
1
|
|
Novel treatment options for anaplastic thyroid cancer, file e0d6c929-c09c-fcf8-e053-d805fe0aa794
|
1
|
|
Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer, file e0d6c92c-cfd7-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92c-f275-fcf8-e053-d805fe0aa794
|
1
|
|
Clinical profile of juvenile primary hyperparathyroidism: a prospective study, file e0d6c92d-09ad-fcf8-e053-d805fe0aa794
|
1
|
|
Sorafenib and Thyroid Cancer, file e0d6c92d-3448-fcf8-e053-d805fe0aa794
|
1
|
|
Robotic transaxillary thyroidectomy: state of the art, file e0d6c92e-d0d3-fcf8-e053-d805fe0aa794
|
1
|
|
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases, file e0d6c92f-1195-fcf8-e053-d805fe0aa794
|
1
|
|
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer?, file e0d6c92f-7c24-fcf8-e053-d805fe0aa794
|
1
|
|
First report of benign track seeding after robot-assisted transaxillary thyroid surgery, file e0d6c92f-e448-fcf8-e053-d805fe0aa794
|
1
|
|
Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses, file e0d6c932-44f0-fcf8-e053-d805fe0aa794
|
1
|
| Totale |
4.437 |